Is Kalbe Farma (KLBF) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.2% / 30% | 10.5% / 30% | 10.5% / 30% | 0.55% / 5% | ✓ HALAL |
| DJIM | 1.2% / 33% | 10.5% / 33% | 10.5% / 33% | 0.55% / 5% | ✓ HALAL |
| MSCI | 1.9% / 33% | 16.5% / 33% | 16.5% / 33% | 0.55% / 5% | ✓ HALAL |
| S&P | 1.2% / 33% | 10.5% / 33% | 10.5% / 33% | 0.55% / 5% | ✓ HALAL |
| FTSE | 1.9% / 33% | 16.5% / 33% | 16.5% / 50% | 0.55% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 39.9% | |
| Operating Margin | 9.6% | |
| Net Margin | 10.2% | |
| Return on Equity (ROE) | 14.6% | |
| Return on Assets (ROA) | 9.3% |
Cash Flow & Balance Sheet
| Free Cash Flow | $3.5T |
| Total Debt | $559.2B |
| Debt-to-Equity | 2.1 |
| Current Ratio | 3.9 |
| Total Assets | $29.4T |
Price & Trading
| Last Close | IDR 985.00 |
| 50-Day MA | IDR 1,072.20 |
| 200-Day MA | IDR 1,233.42 |
| Avg Volume | 52.4M |
| Beta | -0.0 |
|
52-Week Range
IDR 950.00
| |
About Kalbe Farma (KLBF)
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Purification Calculator
As a halal stock with 0.55% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Kalbe Farma (KLBF) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Kalbe Farma is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Kalbe Farma's debt ratio?
Kalbe Farma's debt ratio is 1.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 1.9%.
Does Kalbe Farma require dividend purification?
Yes, Kalbe Farma has an impermissible income ratio of 0.55%, which means 0.55% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Kalbe Farma's key financial metrics?
Kalbe Farma has a market capitalization of $43.6T, trailing P/E ratio of 12.5, and revenue of $32.6T. The company maintains a gross margin of 39.9% and a net margin of 10.2%. Return on equity stands at 14.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.